Cargando…
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A
Charcot–Marie-Tooth disease type 2A (CMT2A) is an untreatable childhood peripheral neuropathy caused by mutations of the mitochondrial fusion protein, mitofusin (MFN) 2. Here, pharmacological activation of endogenous normal mitofusins overcame dominant inhibitory effects of CMT2A mutants in reprogra...
Autores principales: | Franco, Antonietta, Dang, Xiawei, Walton, Emily K, Ho, Joshua N, Zablocka, Barbara, Ly, Cindy, Miller, Timothy M, Baloh, Robert H, Shy, Michael E, Yoo, Andrew S, Dorn, Gerald W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655101/ https://www.ncbi.nlm.nih.gov/pubmed/33074106 http://dx.doi.org/10.7554/eLife.61119 |
Ejemplares similares
-
Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation
por: Dang, Xiawei, et al.
Publicado: (2022) -
Reciprocal Regulation of Mitofusin 2-Mediated Mitophagy and Mitochondrial Fusion by Different PINK1 Phosphorylation Events
por: Li, Jiajia, et al.
Publicado: (2022) -
Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2A
por: Dorn, Gerald W.
Publicado: (2021) -
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
por: Franco, Antonietta, et al.
Publicado: (2022) -
Mitochondria Clumping vs. Mitochondria Fusion in CMT2A Diseases
por: Franco, Antonietta, et al.
Publicado: (2022)